comparemela.com

Latest Breaking News On - பிராந்திய செயல்பாட்டு ப்ரோக்ர்யாம் - Page 1 : comparemela.com

Major restoration works on Heroes Cross, completed; DefMin Ciuca: Military managed to live up to mission

Major restoration works on Heroes Cross, completed; DefMin Ciuca: Military managed to live up to mission
stiripesurse.ro - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from stiripesurse.ro Daily Mail and Mail on Sunday newspapers.

Νέα Βάση Ανοιχτών Δεδομένων για δημόσιες συμβάσεις τεχνικών - κατασκευαστικών έργων

Νέα Βάση Ανοιχτών Δεδομένων για δημόσιες συμβάσεις τεχνικών - κατασκευαστικών έργων
news247.gr - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news247.gr Daily Mail and Mail on Sunday newspapers.

Italfarmaco Announces Topline Data from Phase 2 Trial with Givinostat in Patients with Becker Muscular Dystrophy

Posted on 8181 Italfarmaco Group announced today topline data from its proof-of-concept Phase 2 trial with Givinostat, the company’s proprietary histone deacetylase (HDAC) inhibitor, in 51 adult males with Becker Muscular Dystrophy (BMD). The study was designed to evaluate the effect of Givinostat in BMD, building on the experience developed in Duchenne Muscular Dystrophy. Based on this experience, change in total fibrosis in the muscle biopsy was selected as the primary endpoint of the study and change in fat fraction and contractile CSA using quantitative Magnetic Resonance Imaging (MRI) as key secondary endpoints. Givinostat did not show significant difference in the primary endpoint compared to placebo. However, significant difference from placebo in MRI of muscles in the whole thigh as well as quadriceps confirmed the ability of Givinostat to counteract muscle deterioration in the treated BMD patients. The safety

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.